Evidence map›Paper›PMID 34204214›Full record

ArticleInternational journal of molecular sciences2021

Exploring the Interaction of Curaxin CBL0137 with G-Quadruplex DNA Oligomers.

Sabrina Dallavalle, Luce M Mattio, Roberto Artali, Loana Musso, Anna Aviñó, Carme Fàbrega, Ramon Eritja, Raimundo Gargallo, Stefania Mazzini

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. The interactions of Pu22 G-quadruplex, derived fromMolecular therapy. Nucleic acids · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Sabrina DallavalleDepartment of Food, Environmental and Nutritional Sciences (DEFENS), University of Milan (Università degli Studi di Milano), 20133 Milan, Italy.ORCID 0000-0002-8813-8922
Luce M MattioDepartment of Food, Environmental and Nutritional Sciences (DEFENS), University of Milan (Università degli Studi di Milano), 20133 Milan, Italy.ORCID 0000-0003-0955-3982
Roberto ArtaliScientia Advice di Roberto Artali, 20832 Desio, Italy.ORCID 0000-0002-6289-5546
Loana MussoDepartment of Food, Environmental and Nutritional Sciences (DEFENS), University of Milan (Università degli Studi di Milano), 20133 Milan, Italy.ORCID 0000-0002-6838-7753
Anna AviñóInstitute for Advanced Chemistry of Catalonia (IQAC), CSIC, Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08034 Barcelona, Spain.
Carme FàbregaInstitute for Advanced Chemistry of Catalonia (IQAC), CSIC, Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08034 Barcelona, Spain.ORCID 0000-0003-3816-7634
Ramon EritjaInstitute for Advanced Chemistry of Catalonia (IQAC), CSIC, Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08034 Barcelona, Spain.ORCID 0000-0001-5383-9334
Raimundo GargalloDepartment of Chemical Engineering and Analytical Chemistry, University of Barcelona, 08028 Barcelona, Spain.ORCID 0000-0001-8716-8356
Stefania MazziniDepartment of Food, Environmental and Nutritional Sciences (DEFENS), University of Milan (Università degli Studi di Milano), 20133 Milan, Italy.ORCID 0000-0002-8220-0502
University of Milan · ITBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESUniversitat de Barcelona · ES

Funding

by PIANO DI SOSTEGNO ALLA RICERCA 2020 Linea 2 azione B (DEFENS).
6 · The paper itself

Abstract

Curaxins and especially the second-generation derivative curaxin CBL0137 have important antitumor activities in multiple cancers such as glioblastoma, melanoma and others. Although most of the authors suggest that their mechanism of action comes from the activation of p53 and inactivation of NF-kB by targeting FACT, there is evidence supporting the involvement of DNA binding in their antitumor activity. In this work, the DNA binding properties of curaxin CBL0137 with model quadruplex DNA oligomers were studied by

Indexed as

G-QuadruplexesCarbazolesDNAHumansMacromolecular SubstancesMagnetic Resonance SpectroscopyMolecular ConformationMolecular StructureStructure-Activity RelationshipTelomereCarbazolesCBLC137DNAMacromolecular Substancescircular dichroismc-myccuraxinDNA interactionsG-quadruplexmolecular modelingNMR spectroscopy

Identifiers

PMID34204214
PMCPMC8234370
OpenAlexW3166655316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.